Build a lasting personal brand

Watchdog Demands Federal Oversight as Antipsychotic Use in Seniors Climbs Nearly 52%

By Advos•
A federal watchdog report shows nursing homes still use antipsychotics as chemical restraints on elderly residents, prompting CCHR International to demand stricter oversight and a ban on electroshock for seniors.
Watchdog Demands Federal Oversight as Antipsychotic Use in Seniors Climbs Nearly 52%

A federal watchdog report has found that nursing homes continue using antipsychotics as chemical restraints, sometimes without first attempting required non-drug interventions, according to the Citizens Commission on Human Rights (CCHR) International. National data showed antipsychotic use among adults aged 65 and older increased nearly 52% between 2015 and 2024, while long-term use increased almost 65%.

The finding matters beyond the nursing home industry because the drugs carry severe side effects for elderly people with dementia. The Food and Drug Administration issued a boxed warning against their use in this population because of the increased risk of death. Studies link newer antipsychotics in older adults with dementia to sharply higher risks of stroke, heart failure, accelerated cognitive decline, and bone fractures from falls.

The Health and Human Services Office of Inspector General has flagged the sedative effect of these drugs, raising concerns that nursing homes may use them to control residents' behavior for the benefit of staff. Investigators found that some medical directors failed to prevent inappropriate use, nursing home pharmacists did not identify medical concerns or recommend dose reductions, and inadequate policies undermined safeguards meant to protect residents. This persists even though the Centers for Medicare & Medicaid Services has taken steps to discourage the practice.

Lori Smetanka, executive director of the National Consumer Voice for Quality Long-Term Care, described the human cost: "Instead of getting to the root problem and addressing the problem, we're quieting them down. And then that's what leads to significant problems with their health and well-being."

CCHR is also pressing for a prohibition on electroconvulsive therapy, or electroshock, for the elderly. Nearly every person diagnosed with dementia, up to an estimated 97%, will eventually experience changes in mood, perception or behavior, placing them at risk of both psychotropic drugs and ECT, the passage of up to 460 volts of electricity through the brain to induce a grand-mal seizure in frail bodies. A clinical neuropsychology study of 62 non-demented elderly depressed patients found that 40% showed significant individual-level decline within one week after ECT. A 1993 Brown University study of patients 80 and older found that 27% of those given ECT were dead within one year compared with 4% of a similar, untreated group, a disparity documented in http://usatoday30.usatoday.com/life/health/lhs195.htm.

Jan Eastgate, president of CCHR International, said the cumulative picture is one of institutionalization that too often relies on drugs, ECT and restraints rather than addressing root causes. CCHR encourages reporting psychiatric abuse of the elderly and advises individuals to contact their Congressional and state representatives to demand strict enforcement of non-drug interventions and a prohibition on electroshock. The group has previously urged oversight of elderly patients being electroshocked, as detailed in its https://www.cchrint.org/2021/05/17/cchr-urges-mental-health-month-oversight-of-elderly-being-electroshocked/.

For families with relatives in long-term care, the report signals that promised safeguards may not be working, and that non-drug alternatives remain unevenly enforced. For the industry, it raises the prospect of tighter federal scrutiny and potential penalties as regulators weigh whether existing CMS guidance has failed to curb the practice.

Advos

Advos

@advos